Kintara Therapeutics Inc. sell bundfuture
Start price
01.12.22
/
50%
€8.82
Target price
01.12.23
-
Performance (%)
57.03%
End price
10.12.22
€13.85
Summary
This prediction ended on 10.12.22 with a price of €13.85. The SELL prediction by bundfuture for Kintara Therapeutics Inc. was trending in the completely wrong direction and closed with a performance of 57.03%. bundfuture has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kintara Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |
According to bundfuture what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by bundfuture for this prediction
In the thread Kintara Therapeutics Inc. diskutieren
Sell Kintara Therapeutics Inc.